Translating reference doses into allergen management practice: Challenges for stakeholders

Food and Chemical Toxicology

Volumn 67, Issue , 2014, Pages 277-287

  Crevel, René W R ^a   Baumert, Joseph L ^b   Luccioli, Stefano ^c   Baka, Athanasia ^d   Hattersley, Sue ^e   Hourihane, Jonathan O'B ^f   Ronsmans, Stefan ^g   Timmermans, Frans ^h   Ward, Rachel ⁱ   Chung, Yong joo ^j  

^a UNILEVER RESEARCH   (United Kingdom)

^b UNIVERSITY OF NEBRASKA LINCOLN   (United States)

^c CENTER FOR DRUG EVALUATION AND RESEARCH   (United States)

^d International Life Sciences Institute of Europe   (Belgium)

^e FOOD STANDARDS AGENCY   (United Kingdom)

^f UNIVERSITY COLLEGE CORK   (Ireland)

^g Coca Cola Services ^*  (Belgium)

^h Nederlands Anafylaxis Netwerk European Anaphylaxis Taskforce   (Netherlands)

ⁱ R Ward Consultancy Limited   (United Kingdom)

^j NESTLÉ RESEARCH CENTER   (Switzerland)

more..

Author keywords

Eliciting dose; Food allergy; Probabilistic modelling; Public health; Reference dose; Risk assessment

Indexed keywords

FOOD ALLERGEN; ALLERGEN;

CONSUMER ATTITUDE; CONSUMER HEALTH INFORMATION; DECISION MAKING; FOOD INDUSTRY; FOOD PACKAGING; HEALTH PERSONNEL ATTITUDE; HUMAN; INFORMATION DISSEMINATION; POPULATION RISK; PUBLIC HEALTH; QUANTITATIVE ANALYSIS; REFERENCE VALUE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; RISK REDUCTION; DOSE RESPONSE; TOXICITY;

ALLERGENS; DOSE-RESPONSE RELATIONSHIP, IMMUNOLOGIC; HUMANS;

EID: 84897956923     PISSN: 02786915     EISSN: 18736351     Source Type: Journal    
DOI: 10.1016/j.fct.2014.01.033     Document Type: Review

References (32)

1. Allen K.J., Remington B.C., Baumert J.L., Crevel R.W., Houben G.F., Brooke-Taylor S., Kruizinga A.G., Taylor S.L. Allergen reference doses for precautionary labeling (VITAL 2.0): clinical implications. J. Allergy Clin. Immunol. 2013.
2. Allergen Bureau, 2012 Voluntary Incidental Trace Allergen Labelling (VITAL).
3. Barnett J., Leftwich J., Muncer K., Grimshaw K., Shepherd R., Raats M.M., Gowland M.H., Lucas J.S. How do peanut and nut-allergic consumers use information on the packaging to avoid allergens?. Allergy 2011, 66:969-978.
4. Barnett J., Muncer K., Leftwich J., Shepherd R., Raats M.M., Gowland M.H., Grimshaw K., Lucas J.S. Using 'may contain' labelling to inform food choice: a qualitative study of nut allergic consumers. BMC Public Health 2011, 11:734.
5. Boyce J.A., Assa'ad A., Burks A.W., Jones S.M., Sampson H.A., Wood R.A., Plaut M., Cooper S.F., Fenton M.J., Arshad S.H., Bahna S.L., Beck L.A., Byrd-Bredbenner C., Camargo C.A., Eichenfield L., Furuta G.T., Hanifin J.M., Jones C., Kraft M., Levy B.D., Lieberman P., Luccioli S., Mccall K.M., Schneider L.C., Simon R.A., Simons F.E., Teach S.J., Yawn B.P., Schwaninger J.M. Guidelines for the diagnosis and management of food allergy in the United States: report of the NIAID-sponsored expert panel. J. Allergy Clin. Immunol. 2010, 126:S1-S58.
6. Christie L., Hine R.J., Parker J.G., Burks W. Food allergies in children affect nutrient intake and growth. J. Am. Diet. Assoc. 2002, 102:1648-1651.
7. Cochrane S.A., Gowland M.H., Sheffield D., Crevel R.W.R. Characteristics and purchasing behaviours of food-allergic consumers and those who buy food for them in Great Britain. Clin. Transl. Allergy 2013, 3:31.
8. Crotty M.P., Taylor S.L. Risks associated with foods having advisory milk labeling. J Allergy Clin. Immunol. 2010, 125:935-937.
9. Cvetkovich G., Earle T. Environmental hazards and the public. J. Social Issues 1992, 48:1-20.
10. Earle, T., Cvetkovich, G., 1995. Social Trust: Toward a Cosmopolitan SocietyPraeger, Westport, CT.
11. Federal Register, 2013 Food Labeling; Gluten-Free Labeling of Foods. 21 CFR part 101 ed.
12. Health Council of the Netherlands, 2007 Food allergy. Publication no. 2007/07 ed. The Hague.
13. Hefle S.L., Furlong T.J., Niemann L., Lemon-Mule H., Sicherer S., Taylor S.L. Consumer attitudes and risks associated with packaged foods having advisory labeling regarding the presence of peanuts. J Allergy Clin. Immunol. 2007, 120:171-176.
14. Kasperson R.E.D., Golding D., Tuler S. Siting hazardous facilities and communicating risks under conditions of high social distrust. J. Social Issues 1992, 48:161-172.
15. Leiss W. Three phases in the evolution of risk communication practice. Ann. Am. Acad. Political Social Sci. 1996, 545:85-94.
16. Leung D.Y., Sampson H.A., Yunginger J.W., Burks A.W., Schneider L.C., Wortel C.H., Davis F.M., Hyun J.D., Shanahan W.R. Effect of anti-IgE therapy in patients with peanut allergy. N. Engl. J. Med. 2003, 348:986-993.
17. Leung D.Y., Shanahan W.R., Sampson H.A. Response to "effect of anti-IgE therapy in patients with food allergy". Ann. Allergy Asthma Immunol. 2003, 91:515-517.
18. Lofstedt, R.E., Horlick-Jones, T., 1999. Environmental regulation in the UK: politics, institutional change and public trust. In: Cvetkovich, G., Lofstedt, R.E. (Eds.), Social Trust and the Management of Risk Earthscan, London.
19. Madsen C.B., Crevel R., Chan C.H., Dubois A.E., Dunngalvin A., Flokstra-de Blok B.M., Gowland M.H., Hattersley S., Hourihane J.O., Norhede P., Pfaff S., Rowe G., Schnadt S., Vlieg-Boerstra B.J. Food allergy: stakeholder perspectives on acceptable risk. Regul. Toxicol. Pharmacol. 2010, 57:256-265.
20. Madsen C.B., Hattersley S., Allen K.J., Beyer K., Chan C.H., Godefroy S.B., Hodgson R., Mills E.N., Munoz-Furlong A., Schnadt S., Ward R., Wickman M., Crevel R. Can we define a tolerable level of risk in food allergy? Report from a EuroPrevall/UK Food Standards Agency workshop. Clin Exp. Allergy 2012, 42:30-37.
21. Pieretti M.M., Chung D., Pacenza R., Slotkin T., Sicherer S.H. Audit of manufactured products: use of allergen advisory labels and identification of labeling ambiguities. J. Allergy Clin. Immunol. 2009, 124:337-341.
22. Rance F., Grandmottet X., Grandjean H. Prevalence and main characteristics of schoolchildren diagnosed with food allergies in France. Clin. Exp. Allergy 2005, 35:167-172.
23. Renn O. Risk communication and the social amplification of risk. Communicating Risks to the Public: International Perspectives 1991, Kluwer, Dordrecht. R.E.D. Kasperson, P.J. Stallen (Eds.).
24. Rimbaud L., Heraud F., La Vieille S., Leblanc J.C., Crepet A. Quantitative risk assessment relating to adventitious presence of allergens in food: a probabilistic model applied to peanut in chocolate. Risk Anal. 2010, 30:7-19.
25. Rolinck-Werninghaus C., Niggemann B., Grabenhenrich L., Wahn U., Beyer K. Outcome of oral food challenges in children in relation to symptom-eliciting allergen dose and allergen-specific IgE. Allergy 2012, 67:951-957.
26. Siegrist M. The influence of trust and perceptions of risks and benefits on the acceptance of gene technology. Risk Anal. 2000, 20:195-203.
27. Siegrist M. Perception of gene technology and food risks: results of a survey in Switzerland. J. Risk Res. 2003, 6:45-60.
28. Slovic P. Perceived risk, trust, and democracy. Risk Anal. 1993, 13:675-682.
29. Slovic, P., Macgregor, D., 1994. The Social Context of Risk Communication Decision Research, Eugene, Oregon.
30. Taylor S.L., Baumert J.L., Kruizinga A.G., Remington B.C., Crevel R.W., Brooke-Taylor S., Allen K.J., Houben G. Establishment of reference doses for residues of allergenic foods: report of the VITAL expert panel. Food Chem. Toxicol. 2014, 63:9-17.
31. Wainstein B.K., Studdert J., Ziegler M., Ziegler J.B. Prediction of anaphylaxis during peanut food challenge: usefulness of the peanut skin prick test (SPT) and specific IgE level. Pediatr. Allergy Immunol. 2010, 21:603-611.
32. Zurzolo G.A., Allen K.J., Taylor S.L., Shreffler W.G., Baumert J.L., Tang M.L.K., Gurrin L.C., Mathai M.L., Nordlee J.A., Dunngalvin A., Hourihane J.O'B Allergy Asthma Clin. Immunol. 2013, 9:35. http://www.aacijournal.com/content/9/1/35